A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Participants With Guillain-Barré Syndrome (GBS)
Clinical trial NCT05494619 · WITHDRAWN
Trial details
- NCT number
- NCT05494619
- Sponsor
- Hoffmann-La Roche
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2026-03-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.